In conclusion, the cadherin and Wnt signaling pathways might represent promising targets in developing new treatments to prevent not only DN caused by both T1DM and T2DM but a variety of proteinuric kidney diseases in humans and the cytokines and chemokines could also constitute potential therapeutic targets in DN. Here, CDH17 is linked to type 2 diabetes mellitus.